INO Research and Charts

INO - Inovio Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-07-11)

Last 1.36	Change ⇓ -0.03 (-2.16%)	Volume 1,782,842
	Open 1.36	High 1.40	Low 1.34

8EMA (Daily) 1.58	40EMA (Daily) 1.89	50EMA (Daily) 1.91	STO (Daily) 7.400	MACD Hist (Daily) -0.167
8EMA (Weekly) 1.893	40EMA (Weekly) 3.06	50EMA (Weekly) 3.63	STO (Weekly) 55.784	MACD Hist (Weekly) 0.219


Company Profile
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.